Prevalence of Inhaled Corticosteroid Use among Patients with Chronic Obstructive Pulmonary Disease: A Survey
Annals of PharmacotherapyPublished 1 February 1997
Cynthia A. Jackevicius, Kenneth R. Chapman
Citations43
SJR quartileQ2
SJR score0.79
SNIP0.97
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The rate of inhaled corticosteroid use far exceeds the rate expected among the general population of patients with COPD, and educational intervention is needed to encourage compliance with published guidelines for the management of COPD.
Abstract
OBJECTIVE: To determine the extent of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease (COPD). DESIGN: Review of medical records. SETTING: Tertiary-care university teaching hospital. PATIENTS: Seventy-two consecutive patients prescribed an inhaled corticosteroid during hospitalization. INTERVENTION: None. MEASUREMENTS: Patient demographics, inhaled corticosteroid regimen, respiratory diagnosis, and inhaled corticosteroid use before and during hospitalization. RESULTS: The majority of patients (85%) were receiving their prescribed corticosteroid inhaler prior to admission. Beclomethasone dipropionate 250 micrograms/puff was the most commonly prescribed inhaled corticosteroid formulation accounting for 43% of the total corticosteroid inhaler orders. COPD was the most common respiratory diagnosis (43%) associated with inhaled corticosteroid use, followed by asthma (37%), COPD/asthma (13%), and no diagnosis (7%). During the study period, the proportion of all hospitalized patients with COPD who also received inhaled corticosteroid prescriptions (35%) was not significantly different from all hospitalized patients with asthma who received inhaled corticosteroid prescriptions (33%). CONCLUSIONS: The rate of inhaled corticosteroid use far exceeds the rate expected among the general population of patients with COPD. Educational intervention is needed to encourage compliance with published guidelines for the management of COPD.
Keywords
Medicine
New England Journal of MedicineA New Approach to the Treatment of Asthma
451 Citations1989John A. Oates, Alastair J.J. Wood +1 more
Effective suppression of airway inflammation reduces the need for bronchodilator therapy and may reduce the morbidity and, perhaps, mortality of asthma.
New England Journal of MedicineA Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease
339 Citations1992Huib A.M. Kerstjens, Paul L.P. Brand +10 more
In the corticosteroid group, patients who did not smoke, who had allergies, or who were less than 40 years old benefited more from their treatment than did those who smoked, did not have allergy, or were over 40.
The American Journal of MedicineAdverse effects of inhaled corticosteroids
295 Citations1995Nicola A. Hanania, Kenneth R. Chapman +1 more
Although inhaled steroids should, at the present time, continue to be a recommended therapeutic option to all patients with symptomatic asthma, they should always be used in the lowest dosage compatible with disease control.
Annals of Internal MedicineOral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary Disease
232 Citations1991Christopher M. Callahan, Robert S. Dittus +1 more
Patients with stable chronic obstructive pulmonary disease receiving oral corticosteroid therapy have a 20% or greater improvement in baseline FEV1 approximately 10% more often than similar patients receiving placebo.
New England Journal of MedicineManagement of Chronic Obstructive Pulmonary Disease
185 Citations1993Jane F. Desforges, Gary T. Ferguson +1 more
CHEST JournalPhysician Perceptions and Management of COPD
144 Citations1993Steven Kesten, Kenneth R. Chapman
Primary care practitioners have a low index of suspicion for obstructive airway disease, markedly underutilized spirometry as a screening tool, consider beta 2-agonists first-line therapy for COPD and asthma, and despite considering COPDand asthma different disease processes, choose similar medications for each disorder.
ThoraxEffect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study.
128 Citations1988Christine Jenkins, Ann J. Woolcock
At doses that had similar beneficial effects on lung function beclomethasone dipropionate caused a significant improvement in bronchial hyperresponsiveness whereas prednisone caused no change.
EpilepsiaDose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial
122 Citations1995Joyce A. Cramer, Luc Vachon +2 more
Medication monitoring showed differences in dose frequency compliance and dose interval compliance between investigational and concomitant medications, as well as study protocol noncompliance, by outpatients in a long‐term clinical trial.
ThoraxCorticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.
112 Citations1990D C Weir, R. I. Gove +2 more
Inhaled beclomethasone dipropionate 500 micrograms thrice daily was inferior to oral prednisolone 40 mg per day, but better than placebo, in producing improvement in physiological measurements in patients thought to have nonasthmatic chronic airflow obstruction.
European Respiratory JournalModerately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
108 Citations1988DS Postma, Inga Peters +2 more
The present long-term study on 139 non-allergic patients with less severe CAO confirms and extends the former observations that daily oral corticosteroids might slow down the progression of disease and shows a strong association with the long- term use of prednisolone.
American Review of Respiratory DiseaseAerosolized Beclomethasone in Chronic Bronchitis: Improved Pulmonary Function and Diminished Airway Inflammation
94 Citations1992Austin B. Thompson, Mary Mueller +6 more
After treatment, the beclomethasone group, but not the placebo group, showed improvement in FVC, FEV1, and 25 to 75% forced expiratory flow, and Associated with the improvement in spirometry, the bronchitis index fell.
ThoraxEffects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.
82 Citations1991B Auffarth, Dirkje S. Postma +4 more
There was a significant reduction in dyspnoea in the budesonide group, but otherwise no change in symptom scores or use of ipratropium bromide over the eight weeks of treatment within or between the two groups.
ThoraxA comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.
82 Citations1978Stuart M. Harding, S. Freedman
The steroid aerosol produced a good improvement in ventilatory capacity in the responsive patients who were hospitalised and this was thought to be helped by supervision of aerosol technique.
CHEST JournalCorticosteroids in COPD
79 Citations1986Orn Eliasson, Joseph G. Hoffman +3 more
It appears that previous studies of corticosteroids in COPD may have overestimated the number of COPD patients who might benefit from corticosterone, due to a bias resulting from the selection of severely obstructed subjects.
PubMedCompliance differences following administration of theophylline at six- and twelve-hour intervals.
77 Citations1980Tinkelman Dg, Vanderpool Ge +3 more
This study evaluated the compliance differences between administration of theophylline at six and 12-hour intervals in a pediatric outpatient population.
Clinical CardiologyMaintaining long-term control of blood pressure: The role of improved compliance
63 Citations1995Neville Bittar
Many studies have found that compliance increases as drug‐dosage frequency decreases, as with the use of once‐daily or sustained‐release drug preparations, and other contributors to compliance include prescription‐refill reminders, appointment reminders, and patient education about the need for treatment and the consequences of noncompliance.
CHEST JournalInhaled Budesonide Therapy for Patients With Stable COPD
59 Citations1995P Weiner, Margalit Weiner +2 more
It is concluded that treatment with inhaled steroids improved spirometry data and inhaled beta 2-agonist consumption in about 25% of patients with stable COPD, and this rate is increased to about 75% in patients who respond to beta 1-agonist inhalation.
European Respiratory JournalA trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis
56 Citations1989Tal Engel, JH Heinig +3 more
A moderately high dose of inhaled steroid in eight subjects with chronic bronchitis did not improve the symptom scores, ventilatory capacity, or airway responsiveness to any clinically relevant degree.
The American Journal of MedicineAerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease
44 Citations1985Chang Shim, M. Henry Williams
In most patients with steroid-responsive chronic obstructive pulmonary disease, aerosol beclomethasone is not an adequate substitute for oral steroids, and the benefit of long-term steroid therapy may be outweighed by the side effects.
CHEST JournalIntravenous and Oral Corticosteroids for the Prevention of Relapse after Treatment of Decompensated COPD
41 Citations1990Glen H. Murata, Michael S. Gorby +2 more
For patients with a history of multiple relapses, a regimen consisting of intravenous and oral corticosteroids reduces the risk of relapse after ED treatment of decompensated COPD.
Journal of Allergy and Clinical ImmunologyTrends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990
32 Citations1993Steven Kesten, A. S. Rebuck +1 more
The increase in airway medication prescriptions dispensed in Canada is consistent with an increase in the number of patients treated, an increaseIn the severity of disease treated, or both.
Annals of PharmacotherapyMeta-Analysis of Controlled Trials of Drug Therapy in Mild Chronic Asthma: The Role of Inhaled Corticosteroids
19 Citations1994Gary Milavetz, H. William Kelly +3 more